Finance

Lists
ARDT:NYSE
Ardent Health Inc
$17.80
+0.79%
(+0.14) 1D
$17.80
0.00% (0.00)
After hours
Closed: Nov 13, 4:00:02 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ARDT...
Open
$18.07
High
$18.22
Low
$17.39
Mkt. cap
2.51B
Avg. vol.
710.60K
Volume
779.52K
P/E ratio
17.29
52-wk high
$18.57
52-wk low
$7.71
EPS
$1.03
Shares outstanding
140.94M
No. of employees
22K
Open
$18.07
High
$18.22
Low
$17.39
Mkt. cap
2.51B
Avg. vol.
710.60K
Volume
779.52K
P/E ratio
17.29
52-wk high
$18.57
52-wk low
$7.71
EPS
$1.03
Shares outstanding
140.94M
No. of employees
22K
News stories
From web sources and news partners
About Ardent Health Inc
CEO-
Employees22.4K
Founded2001
Headquarters-
SectorHealth Care
IndustryHealth care provider
Websiteardenthealth.com
Analyst ratings
Based on 9 analysts giving stock ratings to ARDT in the past 3 months
Buy
Buy
6
Hold
2
Sell
1
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for ARDT in the last 3 months.
Highest
Current $17.80
$21.00 (+17.98%)
Average
$17.64 (-0.90%)
Lowest
$13.50 (-24.16%)
Analyst
Recommendation
Action
Price target
Projected
Date
Kevin Fischbeck
Bank of America Securities
Sell
Reiterated
$14.00
-21.3%
11/13/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
$21.00
+18%
11/11/2026
A.J. Rice
UBS
Buy
Reiterated
$20.00
+12.4%
11/09/2026
Sean Dodge
BMO Capital
Hold
Reiterated
$16.00
-10.1%
11/05/2026
Ben Hendrix
RBC Capital
Buy
Reiterated
$18.00
+1.1%
11/06/2026
Craig Hettenbach
Morgan Stanley
Hold
Reiterated
$13.50
-24.2%
11/06/2026
Unknown Analyst
Stephens
Buy
Reiterated
$21.00
+18%
11/06/2026
David S Macdonald
Truist Financial
Buy
Maintained
-
-
09/30/2026
Whit Mayo
Leerink Partners
Buy
Reiterated
-
-
09/17/2026
Scott Fidel
Goldman Sachs
Hold
Maintained
$13.00
-27%
08/10/2026
Jason Cassorla
Guggenheim
Buy
Maintained
$14.00
-21.3%
08/05/2026
Jailendra Singh
Truist Financial
Buy
Reiterated
-
-
06/03/2026
Matthew Gillmor CFA
KeyBanc
Hold
Maintained
-
-
06/03/2026
Irene Nattel
RBC Capital
Buy
Maintained
$13.00
-27%
05/07/2026
Last report
Nov 5, 2026
Fiscal period
Q3 2026
$0.38 / $0.25
+55.02%beat
Revenue / Est. (USD)
1.62B / 1.60B
+1.37%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.61B
1.60B
1.62B
1.62B
Cost of goods sold
651.39M
661.43M
676.19M
647.94M
Cost of revenue
651.39M
661.43M
676.19M
647.94M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
653.77M
651.39M
674.11M
677.70M
Operating expense
848.94M
859.53M
890.29M
884.60M
Total operating expenses
1.50B
1.52B
1.57B
1.53B
Operating income
104.75M
80.91M
55.77M
92.32M
Other non operating income
1.80M
5.89M
-
1.00M
EBT including unusual items
92.37M
74.59M
43.20M
81.02M
EBT excluding unusual items
94.17M
74.59M
43.20M
78.00M
Income tax expense
18.11M
16.10M
8.51M
17.64M
Effective tax rate
19.60%
21.59%
19.71%
21.77%
Other operating expenses
154.13M
165.15M
174.84M
165.84M
Net income
44.96M
39.85M
16.90M
44.52M
Net profit margin
2.80%
2.49%
1.04%
2.74%
Earnings per share
0.36
0.30
0.27
0.38
Interest and investment income
-
-
-
-
Interest expense
-12.38M
-12.21M
-12.57M
-15.32M
Net interest expenses
-12.38M
-12.21M
-12.57M
-15.32M
Depreciation and amortization charges
41.04M
42.99M
41.34M
41.06M
EBITDA
145.79M
123.90M
97.11M
133.37M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps